Bicycle Therapeutics (BCYC) News Today

$22.18
-0.18 (-0.81%)
(As of 05/16/2024 ET)
Bicycle Therapeutics plc (NASDAQ:BCYC) Short Interest Update
Bicycle Therapeutics plc (NASDAQ:BCYC - Get Free Report) was the recipient of a significant decrease in short interest in the month of April. As of April 30th, there was short interest totalling 2,790,000 shares, a decrease of 5.7% from the April 15th total of 2,960,000 shares. Based on an average daily volume of 396,600 shares, the days-to-cover ratio is currently 7.0 days.
Bicycle Therapeutics plc (NASDAQ:BCYC) Shares Acquired by Jump Financial LLC
Jump Financial LLC increased its holdings in shares of Bicycle Therapeutics plc (NASDAQ:BCYC - Free Report) by 108.6% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 77,332 shares of the company's stock af
Bicycle Therapeutics (NASDAQ:BCYC) Shares Down 3.8%
Bicycle Therapeutics (NASDAQ:BCYC) Stock Price Down 3.8%
Bicycle Therapeutics (NASDAQ:BCYC) Earns "Buy" Rating from HC Wainwright
HC Wainwright reiterated a "buy" rating and set a $55.00 price target on shares of Bicycle Therapeutics in a report on Friday.
Bicycle Therapeutics (NASDAQ:BCYC) Announces Earnings Results, Beats Estimates By $0.63 EPS
Bicycle Therapeutics (NASDAQ:BCYC - Get Free Report) released its earnings results on Thursday. The company reported ($0.62) EPS for the quarter, topping the consensus estimate of ($1.25) by $0.63. The firm had revenue of $19.53 million during the quarter, compared to analysts' expectations of $6.06 million. Bicycle Therapeutics had a negative net margin of 669.72% and a negative return on equity of 57.80%. Bicycle Therapeutics's revenue was up 298.9% compared to the same quarter last year.
Bicycle Therapeutics (NASDAQ:BCYC) Trading Up 4.1%
Bicycle Therapeutics (NASDAQ:BCYC) Trading Up 4.1%
Bicycle Therapeutics (NASDAQ:BCYC) Sees Strong Trading Volume
Bicycle Therapeutics (NASDAQ:BCYC) Sees Strong Trading Volume
Bicycle Therapeutics (NASDAQ:BCYC) Shares Down 5.8%
Bicycle Therapeutics (NASDAQ:BCYC) Trading Down 5.8%
Bicycle Therapeutics (NASDAQ:BCYC) Shares Down 4.3%
Bicycle Therapeutics (NASDAQ:BCYC) Stock Price Down 4.3%
Bicycle Therapeutics (NASDAQ:BCYC) Given Buy Rating at Needham & Company LLC
Needham & Company LLC reaffirmed a "buy" rating and issued a $43.00 price target on shares of Bicycle Therapeutics in a research note on Wednesday.
Bicycle Therapeutics plc (NASDAQ:BCYC) Given Average Recommendation of "Moderate Buy" by Brokerages
Shares of Bicycle Therapeutics plc (NASDAQ:BCYC - Get Free Report) have earned an average rating of "Moderate Buy" from the eight analysts that are covering the company, Marketbeat.com reports. One research analyst has rated the stock with a hold recommendation and seven have assigned a buy recom
Insider Selling: Bicycle Therapeutics plc (NASDAQ:BCYC) Insider Sells 790 Shares of Stock
Bicycle Therapeutics plc (NASDAQ:BCYC - Get Free Report) insider Nicholas Keen sold 790 shares of the firm's stock in a transaction dated Wednesday, April 3rd. The stock was sold at an average price of $23.81, for a total value of $18,809.90. Following the transaction, the insider now owns 62,803 shares of the company's stock, valued at $1,495,339.43. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink.
Bicycle Therapeutics (NASDAQ:BCYC) Shares Down 3.1%
Bicycle Therapeutics (NASDAQ:BCYC) Shares Down 3.1%
Take a cool bike ride at Icicle Bicycle
Get Bicycle Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCYC and its competitors with MarketBeat's FREE daily newsletter.

A ‘DeFi Summer’ Projected! (Ad)

Top analysts are predicting DeFi coins to see massive gains in the coming months… During this dubbed ‘DeFi Summer…’ A coin that has been called the “DeFi pioneer” is poised to shoot up 3-7x!

Just click here to learn how you can access this coin right now.

BCYC Media Mentions By Week

BCYC Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BCYC
News Sentiment

0.93

0.55

Average
Medical
News Sentiment

BCYC News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BCYC Articles
This Week

6

3

BCYC Articles
Average Week

Get Bicycle Therapeutics News Delivered to You Automatically

Sign up to receive the latest news and ratings for BCYC and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (NASDAQ:BCYC) was last updated on 5/16/2024 by MarketBeat.com Staff

From Our Partners